Affordable Access

Access to the full text

Industry progress report on neuro-oncology: Biotech update 2013

Authors
  • Ottenhausen, Malte1
  • Bodhinayake, Imithri1
  • Banu, Matei1
  • Kesavabhotla, Kartik1
  • Ray, Ashley1
  • Boockvar, John A.1
  • 1 Weill Cornell Medical College, Department of Neurological Surgery, New York, NY, USA , New York (United States)
Type
Published Article
Journal
Journal of Neuro-Oncology
Publisher
Springer-Verlag
Publication Date
Aug 16, 2013
Volume
115
Issue
2
Pages
311–316
Identifiers
DOI: 10.1007/s11060-013-1222-3
Source
Springer Nature
Keywords
License
Yellow

Abstract

For the second time, The Brain Tumor Center of the Weill Cornell Brain and Spine Center, in collaboration with Voices Against Brain Cancer, hosted The Brain Tumor Biotech Summit in New York City in June 2013. After a very successful first summit in 2012, this innovative event has established a platform for intensive networking between neuro-oncologists, neurosurgeons, neuroscientists, members of the biotechnology and pharmaceutical communities, members of the financial community and leaders of non-profit organizations. This year’s summit highlighted dendritic cell vaccines, novel antibody, heat shock protein and targeted therapies as well as exosome technologies, MRI-guided therapies and other novel drug delivery tools. This report presents a short overview of the current progress in brain tumor research and therapy as presented at the 2013 Brain Tumor Biotech Summit.

Report this publication

Statistics

Seen <100 times